Search research articles
Contact Us
Filters
Showing results (131-140 of 168) with videos related to
Page
of 17
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 25, 2026
Gray Matter Microstructure Measured Using Diffusion Imaging as a Biomarker of Severity in Lewy Body Diseases
Angeliki Zarkali, Ivelina Dobreva, Naomi Hannaway, et al.
Endocrinology
|
December 19, 2015
Identification and Characterization of an Insulin-Like Receptor Involved in Crustacean Reproduction
O Sharabi, R Manor, S Weil, et al.
Brain Communications
|
May 8, 2024
Neuroimaging and plasma evidence of early white matter loss in Parkinson's disease with poor outcomes
Angeliki Zarkali, Naomi Hannaway, Peter McColgan, et al.
Brain Sciences
|
April 3, 2021
Processing of Degraded Speech in Brain Disorders
Jessica Jiang, Elia Benhamou, Sheena Waters, et al.
Parkinsonism & Related Disorders
|
April 8, 2023
Clinical trials for cognition in Parkinson's disease: Where are we and how can we do better?
Ece Bayram, Lucia Batzu, Bension Tilley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 22, 2025
Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes
Naomi Hannaway, Angeliki Zarkali, Rohan Bhome, et al.
Brain : a Journal of Neurology
|
March 11, 2021
Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson's disease
George E C Thomas, Angeliki Zarkali, Mina Ryten, et al.
Neuroimage. Clinical
|
March 30, 2024
A neuroimaging measure to capture heterogeneous patterns of atrophy in Parkinson's disease and dementia with Lewy bodies
R Bhome, S Verdi, S A Martin, et al.
IEEE Transactions on Bio-Medical Engineering
|
May 2, 2025
Noise propagation and MP-PCA image denoising for high-resolution quantitative R<sub>2</sub><sup>*</sup>, T<sub>2</sub><sup>*</sup>, and magnetic susceptibility mapping (QSM)
Liad Doniza, Mitchel Lee, Tamar Blumenfeld-Katzir, et al.
Psychological Medicine
|
March 24, 2025
Minimal clinically important differences for treatment of hallucinations in Parkinson's disease and dementia with Lewy bodies
Suzanne Reeves, Josef Mahdi, Matthew Appleby, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 168) with videos related to
Sort By:
Page
of 17
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 25, 2026
Gray Matter Microstructure Measured Using Diffusion Imaging as a Biomarker of Severity in Lewy Body Diseases
Angeliki Zarkali, Ivelina Dobreva, Naomi Hannaway, et al.
Endocrinology
|
December 19, 2015
Identification and Characterization of an Insulin-Like Receptor Involved in Crustacean Reproduction
O Sharabi, R Manor, S Weil, et al.
Brain Communications
|
May 8, 2024
Neuroimaging and plasma evidence of early white matter loss in Parkinson's disease with poor outcomes
Angeliki Zarkali, Naomi Hannaway, Peter McColgan, et al.
Brain Sciences
|
April 3, 2021
Processing of Degraded Speech in Brain Disorders
Jessica Jiang, Elia Benhamou, Sheena Waters, et al.
Parkinsonism & Related Disorders
|
April 8, 2023
Clinical trials for cognition in Parkinson's disease: Where are we and how can we do better?
Ece Bayram, Lucia Batzu, Bension Tilley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 22, 2025
Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes
Naomi Hannaway, Angeliki Zarkali, Rohan Bhome, et al.
Brain : a Journal of Neurology
|
March 11, 2021
Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson's disease
George E C Thomas, Angeliki Zarkali, Mina Ryten, et al.
Neuroimage. Clinical
|
March 30, 2024
A neuroimaging measure to capture heterogeneous patterns of atrophy in Parkinson's disease and dementia with Lewy bodies
R Bhome, S Verdi, S A Martin, et al.
IEEE Transactions on Bio-Medical Engineering
|
May 2, 2025
Noise propagation and MP-PCA image denoising for high-resolution quantitative R<sub>2</sub><sup>*</sup>, T<sub>2</sub><sup>*</sup>, and magnetic susceptibility mapping (QSM)
Liad Doniza, Mitchel Lee, Tamar Blumenfeld-Katzir, et al.
Psychological Medicine
|
March 24, 2025
Minimal clinically important differences for treatment of hallucinations in Parkinson's disease and dementia with Lewy bodies
Suzanne Reeves, Josef Mahdi, Matthew Appleby, et al.
Page
of 17